Studies show that short – chain fatty acids have different
effects by increasing or decreasing the quantity of certain molecules such as GLP-1,
peptide YY, insulin, glucagon, ghrelin, leptin and serotonin while they also have an
impact on the nervous system. Also is needed to emphasize its role in certain
neurological diseases such as Parkinson, autism spectrum disorder and multiple
sclerosis. However, the current evidence still needs to be strengthened by further
studies that will allow to define the mechanisms by which this relationship takes place
and confirm the impact of this type of metabolites on the organism. At the same time,
this will allow to develop new treatments for people with certain neurological diseases. CLICK TO REVIEW